Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/17/2025

Treatment for Acute Gout

First-Line Treatment Options

  • The American College of Rheumatology recommends first-line treatment for acute gout includes NSAIDs, oral colchicine, or corticosteroids, which should be initiated within 24 hours of symptom onset for optimal outcomes 1, 2, 3
  • Use full FDA-approved anti-inflammatory doses of NSAIDs until the gouty attack has completely resolved 1, 4
  • FDA-approved NSAIDs for acute gout include naproxen (500mg twice daily), indomethacin, and sulindac 4
  • Contraindicated in patients with renal disease, heart failure, or cirrhosis 2, 5
  • Colchicine is most effective when started within 36 hours of symptom onset, with a recommended low-dose regimen: 1.2 mg at first sign of flare, followed by 0.6 mg one hour later (maximum 1.8 mg over a one-hour period) 2
  • Low-dose colchicine regimen is as effective as higher doses with fewer gastrointestinal side effects 2
  • Common side effects of colchicine include diarrhea, nausea, vomiting, cramps, and abdominal pain 2, 5
  • Corticosteroids are considered first-line therapy in patients without contraindications due to their safety profile and low cost, with options including oral, intra-articular, and intramuscular administration 2, 3, 6

Treatment Selection Considerations

  • Renal function should be considered when selecting treatment, with NSAIDs and colchicine dose adjustments recommended in renal impairment 5
  • Cardiovascular disease should be considered when selecting treatment, with colchicine or corticosteroids recommended over NSAIDs 5
  • Gastrointestinal risk should be considered when selecting treatment, with NSAIDs recommended to be used with gastroprotection 5
  • Diabetes should be considered when selecting treatment, with corticosteroids recommended to be used with caution due to potential hyperglycemia 2

Important Principles

  • Initiate treatment within 24 hours of symptom onset for best outcomes 1, 3
  • Continue urate-lowering therapy (if already prescribed) during the acute attack 1, 6
  • For inadequate response, consider adding a second agent 1
  • Continue treatment at full dose until the gouty attack has completely resolved 4

Prophylaxis After Acute Attack

  • Prophylaxis is strongly recommended when starting urate-lowering therapy, with options including low-dose colchicine, low-dose NSAIDs, and low-dose prednisone 1, 3, 4, 6
  • Continue prophylaxis for at least 6 months, or 3 months after achieving target serum urate if no tophi are present, or 6 months after achieving target serum urate if tophi are present 4, 6